CXCL8 and inflammation: Inhibitors of phospholipase D, which specifically cleave phosphatidylcholine (PC) into phosphatidic acid (PA) and choline, could significantly reduce the production of IL-6 and IL-8 in RA-FLS, demonstrating the importance of phospholipid metabolism in synovial inflammation [46].